Back to search

Boston University

Gene expression alterations associated with progression of emphysema and small airway disease in smokers with COPD

Abstract

dc:description.abstract

Chronic Obstructive Pulmonary Disease (COPD) is a disease of reduced lung function. It is the fourth leading cause of death in the US. In the US it is primarily caused by smoking, yet only 10-20% of smokers will develop COPD. The exact molecular and genetic mechanisms contributing to the disease are unknown. Current therapies reduce symptoms but cannot halt the lung function decline. COPD is comprised of two subphenotypes - emphysema (alveolar destruction) and small airway disease (airway-wall thickening). The relative combination of airway disease and emphysema is heterogeneous between patients. The degree of disease is heterogeneous within each patient. This study takes two unique approaches to gain insights into the molecular processes that contribute to airway thickening and alveolar destruction. First, it utilizes the regional heterogeneity in each patient as a surrogate for disease progression. Second, it examines the airway disease and emphysematous components separately. [TRUNCATED]

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Bioinformatics
Grantor dc:publisher
Boston University
Year dc:date.issued
2012

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Gil, Julie Zeskind

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Dc Identifier Other
(ALMA)contemp

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Gil, Julie Zeskind. Gene expression alterations associated with progression of emphysema and small airway disease in smokers with COPD. doctoral thesis, Boston University, 2012. https://hdl.handle.net/2144/12395